Evidence map›Paper›PMID 24393720›Full record

ReviewBioorganic & medicinal chemistry2014

Retinoic acid signaling pathways in development and diseases.

Bhaskar C Das, Pritam Thapa, Radha Karki, Sasmita Das, Sweta Mahapatra, Ting-Chun Liu, Ingrid Torregroza, Darren P Wallace, Suman Kambhampati, Peter Van Veldhuizen and 3 more

Abstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 265 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Bhaskar C DasDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA; Department of Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA; The Kidney Institute, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA. Electronic address: bdas@kumc.edu.
Pritam ThapaDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Radha KarkiDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Sasmita DasDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Sweta MahapatraDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Ting-Chun LiuDepartment of Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.
Ingrid TorregrozaDepartment of Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.
Darren P WallaceThe Kidney Institute, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA.
Suman KambhampatiDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Peter Van VeldhuizenDivision of Hematology and Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA; Molecular Bio-nanotechnology, Imaging and Therapeutic Research Unit, Veteran Affairs Medical Center, Kansas City, MO 64128, USA.
Amit VermaAlbert Einstein College of Medicine, Bronx, NY 10461, USA.
Swapan K RayDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, USA.
Todd EvansDepartment of Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA. Electronic address: tre2003@med.cornell.edu.
University Medical Center · USCornell University · USAlbert Einstein College of Medicine · USUniversity of South Carolina · US

Funding

Regulation of Embryonic Erythropoiesis by BMP SignalingR37HL056182 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVANS, TODD R · 2009 to 2016
$3.2M
Regulation of Embryonic Erythropoiesis by BMP SignalingR01HL056182 · NHLBI · YESHIVA UNIVERSITY · PI EVANS, TODD R · 1997 to 2008
$3.1M
Role of Periostin in Polycystic Kidney DiseaseR01DK081579 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WALLACE, DARREN P. · 2009 to 2018
$3.0M
A molecular pathway controlling cardiomyocyte specification.R01HL111400 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVANS, TODD R · 2012 to 2016
$2.1M
Microsporidiosis: Rational TherapeuticsR56AI093220 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI WEISS, LOUIS M. · 2011 to 2011
$415k
Development of Small Molecule Mimetics of hepatocyte Growth Factor (HGF)R21AA020630 · NIAAA · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAS, BHASKAR CHANDRA, MUESCH, ANNE · 2011 to 2012
$388k
NHLBI NIH HHS HL111400NHLBI NIH HHS HL56182NHLBI NIH HHS R01 HL056182NHLBI NIH HHS R01 HL111400NHLBI NIH HHS R37 HL056182NIAAA NIH HHS AA020630NIAAA NIH HHS R21 AA020630NIAID NIH HHS AI093220NIAID NIH HHS R56 AI093220NIDDK NIH HHS DK081579NIDDK NIH HHS R01 DK081579
6 · The paper itself

Abstract

Retinoids comprise a group of compounds each composed of three basic parts: a trimethylated cyclohexene ring that is a bulky hydrophobic group, a conjugated tetraene side chain that functions as a linker unit, and a polar carbon-oxygen functional group. Biochemical conversion of carotenoid or other retinoids to retinoic acid (RA) is essential for normal regulation of a wide range of biological processes including development, differentiation, proliferation, and apoptosis. Retinoids regulate various physiological outputs by binding to nuclear receptors called retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which themselves are DNA-binding transcriptional regulators. The functional response of RA and their receptors are modulated by a host of coactivators and corepressors. Retinoids are essential in the development and function of several organ systems; however, deregulated retinoid signaling can contribute to serious diseases. Several natural and synthetic retinoids are in clinical use or undergoing trials for treating specific diseases including cancer. In this review, we provide a broad overview on the importance of retinoids in development and various diseases, highlighting various retinoids in the drug discovery process, ranging all the way from retinoid chemistry to clinical uses and imaging.

Indexed as

Signal TransductionAgingAnimalsDrug DiscoveryEyeHumansKidneyMetabolic DiseasesMolecular StructureNeoplasmsTretinoinTretinoinBoron retinoidsChemical biologyNuclear receptorsRetinoic acidRetinoidsRetinoids imagingVitamin A

Identifiers

PMID24393720
PMCPMC4447240
OpenAlexW1972880938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.